newsfilter
← Latest News
GlobeNewswire·

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

  • China SXT Pharmaceuticals, Inc. will consolidate its Class A & Class B ordinary shares at a 1-for-80 ratio effective August 10, 2026.
  • Post-consolidation trading for Class A shares will commence at the market opening on August 10, 2026, under the symbol "SXTC" with new CUSIP G2161P173.
  • Outstanding Class A shares will decrease from 105,704,077 to approximately 1,321,301, with fractional shares rounded up to the next whole share.
  • All outstanding stock options, warrants, & other purchase rights will be adjusted proportionately to reflect the consolidation.
  • Shareholders holding shares through brokers or nominees will have their holdings automatically adjusted without needing to take action.
  • Investors may contact Transhare Corporation, the Company's transfer agent, at +1 303-662-1122 for questions regarding the consolidation.
  • China SXT Pharmaceuticals, founded in 2005 & headquartered in Taizhou City, focuses on the research, development, & sales of processed traditional Chinese medicine.
  • The announcement includes forward-looking statements regarding future events, risks, & financial trends that are subject to uncertainties.